CTIM-18. PHASE 2 STUDY OF PD-1 BLOCKADE WITH PEMBROLIZUMAB PLUS RE-IRRADIATION FOR RECURRENT GLIOBLASTOMA (RGBM) (NCT03661723)

Iwamoto, F., Tanguturi, S., Desai, A., Nayak, L., Uhlmann, E., Wang, T., Lustig, R., Hertan, L., Bagley, S., Hayden, J., Laforest-Roys, C., Muzikansky, A., McCluskey, C., Chukwueke, U., McFaline-Figueroa, J. R., Lee, E., Wen, P. Y., & Reardon, D. (2022). CTIM-18. PHASE 2 STUDY OF PD-1 BLOCKADE WITH PEMBROLIZUMAB PLUS RE-IRRADIATION FOR RECURRENT GLIOBLASTOMA (RGBM) (NCT03661723). Neuro-Oncology, 24(Supplement_7), vii63–vii64. https://doi.org/10.1093/neuonc/noac209.250
Authors:
Fabio Iwamoto
Shyam Tanguturi
Arati Desai
Lakshmi Nayak
Erik J. Uhlmann
Xiaoshan Wang
Robert A. Lustig
Lauren Hertan
Stephen Bagley
Julia Hayden
Corey Laforest-Roys
Alona Muzikansky
Christine McCluskey
Ugonma Chukwueke
J. Ricardo McFaline‐Figueroa
Eudocia Q. Lee
Patrick Y. Wen
David A. Reardon
Affiliated Authors:
Fabio Iwamoto
Publication Type:
Article
Unique ID:
10.1093/neuonc/noac209.250
Journal:
Publication Date:
Data Source:
OpenAlex

Record Created: